This is the text extract for December 2008 Tender results, browse documents here.

---

FAX

Tender Results

To: From: Date: All Suppliers and Wholesalers Yvonne Chen 19 December 2008 No of Pages (including this one): 3

Dear Supplier/Wholesaler TENDER RESULTS The PHARMAC Board (or Chief Executive under delegated authority) has resolved to accept a tender for Sole Subsidised Supply and Hospital Supply Status for a product listed in the Invitation to Tender dated 15 December 2006. Some of the pharmaceuticals that will be delisted when the period of sole supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts until such time as the pharmaceuticals are delisted and PHARMAC will continue to subsidise their pharmaceuticals accordingly. Product Notification Forms Please note that for all changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H) suppliers are required to notify PHARMAC and the Guild by 4pm 12th January 2009. More information and product notification forms can be downloaded from our website – www.pharmac.govt.nz/schedule.asp. 2006/07 Tender Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 1. Tenders awarded to pharmaceuticals where no other brand is listed – subsidy begins on 1 February 2009 and Sole Subsidised Supply commences on 1 May 2009.

The decision was as follows:

Chemical Name Pantoprazole

Presentation; Pack size and type Inj 40 mg; 1 injection, vial

New tender subsidy $8.75

Sole supply brand (Supplier) Pantocid I.V. (API Consumer)

A252330 - qA7633

---

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 1. Tenders awarded to pharmaceuticals where no brand is listed - listing of the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 February 2009 and DV Limits and DV Pharmaceuticals will apply from 1 April 2009.

The decision was as follows:

Chemical Name Pantoprazole

Presentation; Pack size and type Inj 40 mg; 1 injection, vial

Hospital Supply Brand (Supplier) Pantocid I.V. (API Consumer)

Pack Price $8.75

DV Limit 1%

DV Pharmaceuticals Brand Name (Supplier) Somac (Nycomed)

Products where no tender is to be awarded for Sole Subsidised Supply or Hospital Supply Status The PHARMAC Board (or Chief Executive under delegated authority) resolved not to award tenders for Sole Subsidised Supply or Hospital Supply Status for some of the products listed in the Invitation to Tender, dated 15 December 2006.

The decisions were as follows:

Chemical Name

Line Item

Aspirin Ciprofloxacin Crotamiton Desmopressin Desmopressin Hydroxychloroquine Sulphate Megestrol Acetate Mupirocin Promethazine Hydrochloride Stavudine (d4T) Stavudine (d4T)

Tab EC 300 mg Eye Drops 0.3% Crm 10% Tab 100 mcg Tab 200 mcg Tab 200 mg Tab 160 mg Oint 2% Oral liq 5 mg per 5 ml Cap 30 mg Cap 40 mg

2007/08 Tender Products where no tender is to be awarded for Sole Subsidised Supply or Hospital Supply Status The PHARMAC Board (or Chief Executive under delegated authority) resolved not to award tenders for Sole Subsidised Supply or Hospital Supply Status for some of the products listed in the Invitation to Tender, dated 21 December 2007.

The decisions were as follows:

Chemical Name

Line Item

Amiodarone Hydrochloride Amlodipine Amoxycillin Clavulanate Amoxycillin Clavulanate Clindamycin Enoxaparin Sodium

Inj 50 mg per ml, 3 ml Tab 2.5 mg Inj 600 mg Inj 1.2 g Inj phosphate 150 mg per ml, 4 ml Inj 20 mg per 0.2 ml

A252330 - qA7633

---

Chemical Name

Line Item

Enoxaparin Sodium Enoxaparin Sodium Enoxaparin Sodium Hydrocortisone Latanoprost Methotrexate Methotrexate Mometasone Furoate Mometasone Furoate Mometasone Furoate Mometasone Furoate Ondansetron hydrochloride Ondansetron hydrochloride Pizotifen Prednisolone Sodium Phosphate Tenoxicam Testosterone Undecanoate Thalidomide Urea

Inj 40 mg per 0.4 ml Inj 60 mg per 0.6 ml Inj 80 mg per 0.8 ml Inj 50 mg per ml, 2 ml Eye drops 50 mcg per ml Inj 25 mg per ml, 2 ml Inj 25 mg per ml, 20 ml Crm 0.1% (pack size 30 g or less) Crm 0.1% (pack size greater than 30 g) Oint 0.1% (pack size 30 g or less) Oint 0.1% (pack size greater than 30 g) Inj 2 mg per ml, 2 ml Inj 2 mg per ml, 4 ml Tab 500 mcg Oral liq 5 mg per ml Tab 20 mg Cap 40 mg Cap 50 mg Crm 10%

For the remaining products on the Invitation to Tender dated 21 December 2007 and the Invitation to Tender dated 15 December 2006 where no announcement has been made, either a decision is still pending, or is provisional and subject to the product gaining market approval and having sufficient stock. We will keep you informed regarding any changes for the remaining tender products as further decisions are made.

Yours sincerely

Yvonne Chen Tender Analyst

A252330 - qA7633